Use access key #2 to skip to page content.

Ouch, That Stung

Recs

0

April 04, 2007 – Comments (0)

Yet another reason why I've decided to stay away from rating small cap pharma/biotech/biopharma. A company I put the red thumb down on just got bought out. At a big premium to the current price. For a total score of minus 140 points. I decided to stop prolonging the agony and ended the pick. It dropped me a bunch of places and it will take my score weeks to recover. 

The company was Bioveris (BIOV) and it put a severe hurt on my score. 

I'm glad I did this in CAPS and not with real money, that could have been a seriously bad scene.

0 Comments – Post Your Own

Featured Broker Partners


Advertisement